Variant report
Variant | nsv549287 |
---|---|
Chromosome Location | chr1:228257094-228260287 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:13)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:13 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:228251281..228254071-chr1:228258113..228259786,2 | MCF-7 | breast: | |
2 | chr1:228187251..228191319-chr1:228259829..228263819,5 | MCF-7 | breast: | |
3 | chr1:228252404..228256168-chr1:228256803..228260253,5 | MCF-7 | breast: | |
4 | chr1:228256397..228258359-chr1:228260087..228261703,2 | MCF-7 | breast: | |
5 | chr1:228191350..228193786-chr1:228257693..228259549,2 | MCF-7 | breast: | |
6 | chr1:228259486..228261831-chr1:228263458..228267215,4 | MCF-7 | breast: | |
7 | chr1:228249900..228252116-chr1:228255479..228257281,2 | MCF-7 | breast: | |
8 | chr1:228256397..228258359-chr1:228260087..228261703,2 | MCF-7 | breast: | |
9 | chr1:228257466..228261450-chr1:228360954..228363878,3 | K562 | blood: | |
10 | chr1:228230109..228232010-chr1:228259554..228261382,2 | MCF-7 | breast: | |
11 | chr1:228196561..228199539-chr1:228260175..228262293,2 | MCF-7 | breast: | |
12 | chr1:228248925..228252171-chr1:228258918..228261969,3 | MCF-7 | breast: | |
13 | chr1:228246811..228249127-chr1:228257869..228259965,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000181873 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150478428 | chr1:228257143-228257144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs561249363 | chr1:228257146-228257147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531820582 | chr1:228257147-228257148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs112086832 | chr1:228257169-228257170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs371728138 | chr1:228257186-228257187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs543873661 | chr1:228257195-228257196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs372476892 | chr1:228257243-228257244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs145388378 | chr1:228257246-228257247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs149197369 | chr1:228257251-228257252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190476510 | chr1:228257262-228257263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181737265 | chr1:228257273-228257274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565274766 | chr1:228257288-228257289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs145084113 | chr1:228257300-228257301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs532500613 | chr1:228257376-228257377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552782217 | chr1:228257399-228257400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs376263780 | chr1:228257414-228257415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs200595720 | chr1:228257445-228257446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs528919422 | chr1:228257457-228257458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186857418 | chr1:228257472-228257473 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs368048766 | chr1:228257482-228257483 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs548982664 | chr1:228257490-228257491 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs75297048 | chr1:228257502-228257503 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs529870091 | chr1:228257567-228257568 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs28634124 | chr1:228257598-228257599 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs73092923 | chr1:228257620-228257621 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs140892306 | chr1:228257641-228257642 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs549657263 | chr1:228257750-228257751 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs113404293 | chr1:228257761-228257762 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs146051581 | chr1:228257786-228257787 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs193143050 | chr1:228257795-228257796 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs140982654 | chr1:228257835-228257836 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs147207488 | chr1:228257847-228257848 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs185531665 | chr1:228257849-228257850 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs116226949 | chr1:228257862-228257863 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs570117561 | chr1:228257894-228257895 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs190309233 | chr1:228257963-228257964 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs570910984 | chr1:228258097-228258098 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs58014675 | chr1:228258141-228258142 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs373337610 | chr1:228258143-228258144 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs372764645 | chr1:228258146-228258147 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs572674593 | chr1:228258241-228258242 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs542883687 | chr1:228258245-228258246 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs376199964 | chr1:228258285-228258286 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs374958656 | chr1:228258304-228258305 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs576651387 | chr1:228258377-228258378 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs144718134 | chr1:228258391-228258392 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs565336485 | chr1:228258393-228258394 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs116047279 | chr1:228258404-228258405 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs369015589 | chr1:228258430-228258431 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs541384742 | chr1:228258451-228258452 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Autism | 14699429 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Fumarase deficiency | 21572526 | CNVD |
Autism | 17483303 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 17060936 | CNVD |
Myelofibrosis | 22110671 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:228248200-228269000 | Weak transcription | Right Atrium | heart |
2 | chr1:228258400-228258600 | Bivalent Enhancer | Brain Germinal Matrix | brain |
3 | chr1:228258400-228258600 | Enhancers | Esophagus | oesophagus |
4 | chr1:228258600-228269000 | Weak transcription | Esophagus | oesophagus |
5 | chr1:228259600-228262000 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin02 | Skin |
6 | chr1:228260000-228260200 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
7 | chr1:228260000-228260200 | Enhancers | Brain Inferior Temporal Lobe | brain |
8 | chr1:228260000-228260200 | Enhancers | Spleen | Spleen |
9 | chr1:228260000-228260800 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
10 | chr1:228260200-228260600 | Bivalent Enhancer | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr1:228260200-228261800 | Weak transcription | Spleen | Spleen |
12 | chr1:228260200-228268000 | Weak transcription | Gastric | stomach |
13 | chr1:228260200-228269000 | Weak transcription | Brain Inferior Temporal Lobe | brain |